| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Tumor Biology |
Department of Biology, Boston College, Chestnut Hill, Massachusetts 02467 [M. G. M., S. L., T. N. S.], and Department of Physiology, University of Connecticut Health Center, Farmington, Connecticut 06030 [K. P. C.]
Gangliosides are sialated glycosphingolipids present on the plasma membranes of all vertebrate cells. Tumors shed gangliosides into the extracellular microenvironment, which may influence tumor-host cell interactions. We have investigated the role of gangliosides on the growth and angiogenesis of the EPEN experimental mouse brain tumor. EPEN cells express only ganglioside GM3, and the solid tumors formed in vivo are sparsely vascularized with extensive necrosis. We stably transfected the EPEN cells with the cDNA for N-acetylgalactosaminyl transferase, a key enzyme for the synthesis of complex gangliosides. In addition to GM3, the transfected cell line (EPEN-GNT) expressed complex gangliosides GM2, GM1, and GD1a. The EPEN-GNT tumor was more densely vascularized with less necrosis and grew more rapidly than the nontransfected EPEN or mock-transfected (EPEN-V) control tumors. Also, VEGF gene expression was higher in the EPEN-GNT tumor than in the control tumors. The synthesis of complex gangliosides in the EPEN-GNT tumor cells also stimulated vascularization in an in vivo Matrigel assay for angiogenesis. These results indicate that the ratio of GM3 to complex gangliosides can influence the growth and angiogenic properties of the EPEN experimental brain tumor and are consistent with previous findings in other systems. We conclude that gangliosides may be important modulators of brain tumor angiogenesis.
This article has been cited by other articles:
![]() |
T.-W. Chung, S.-J. Kim, H.-J. Choi, K.-J. Kim, M.-J. Kim, S.-H. Kim, H.-J. Lee, J.-H. Ko, Y.-C. Lee, A. Suzuki, et al. Ganglioside GM3 inhibits VEGF/VEGFR-2-mediated angiogenesis: Direct interaction of GM3 with VEGFR-2 Glycobiology, March 1, 2009; 19(3): 229 - 239. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Mukherjee, A. C. Faber, L. M. Shelton, R. C. Baek, T. C. Chiles, and T. N. Seyfried Thematic Review Series: Sphingolipids. Ganglioside GM3 suppresses the proangiogenic effects of vascular endothelial growth factor and ganglioside GD1a J. Lipid Res., May 1, 2008; 49(5): 929 - 938. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Biswas, A. Richmond, P. Rayman, S. Biswas, M. Thornton, G. Sa, T. Das, R. Zhang, A. Chahlavi, C. S. Tannenbaum, et al. GM2 Expression in Renal Cell Carcinoma: Potential Role in Tumor-Induced T-Cell Dysfunction. Cancer Res., July 1, 2006; 66(13): 6816 - 6825. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ogushi, S. Takahashi, T. Takeuchi, T. Urano, K. Horie-Inoue, J. Kumagai, T. Kitamura, Y. Ouchi, M. Muramatsu, and S. Inoue Estrogen Receptor-Binding Fragment-Associated Antigen 9 Is a Tumor-Promoting and Prognostic Factor for Renal Cell Carcinoma Cancer Res., May 1, 2005; 65(9): 3700 - 3706. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Liu, R. Li, and S. Ladisch Exogenous Ganglioside GD1a Enhances Epidermal Growth Factor Receptor Binding and Dimerization J. Biol. Chem., August 27, 2004; 279(35): 36481 - 36489. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Weiss, S. Hettmer, P. Smith, and S. Ladisch Inhibition of Melanoma Tumor Growth by a Novel Inhibitor of Glucosylceramide Synthase Cancer Res., July 1, 2003; 63(13): 3654 - 3658. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Chatterjee, A. Rosner, Y. Han, E. T. Zelazny, B. Li, R. D. Cardiff, and A. S. Perkins Acceleration of Mouse Mammary Tumor Virus-Induced Murine Mammary Tumorigenesis by a p53172H Transgene: Influence of FVB Background on Tumor Latency and Identification of Novel Sites of Proviral Insertion Am. J. Pathol., December 1, 2002; 161(6): 2241 - 2253. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hakomori Glycosylation defining cancer malignancy: New wine in an old bottle PNAS, August 6, 2002; 99(16): 10231 - 10233. [Full Text] [PDF] |
||||
![]() |
G. Zeng, L. Gao, S. Birklé, and R. K. Yu Suppression of Ganglioside GD3 Expression in a Rat F-11 Tumor Cell Line Reduces Tumor Growth, Angiogenesis, and Vascular Endothelial Growth Factor Production Cancer Res., December 1, 2000; 60(23): 6670 - 6676. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |